25th Nov 2016 09:30
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES | ||||
1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: | Futura Medical plc | |||
2 Reason for the notification (please tick the appropriate box or boxes): | ||||
An acquisition or disposal of voting rights | ||||
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached | ||||
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments | ||||
An event changing the breakdown of voting rights | X | |||
Other (please specify): | Aggregation of holdings | |||
3. Full name of person(s) subject to thenotification obligation: | WT Lamb Investments Ltd. | |||
4. Full name of shareholder(s) (if different from 3.): | - | |||
5. Date of the transaction and date onwhich the threshold is crossed orreached: | 22/11/16 | |||
6. Date on which issuer notified: | 24/11/16 | |||
7. Threshold(s) that is/are crossed orreached: | 4% | |||
8. Notified details: |
| ||||||||||||||||||
A: Voting rights attached to shares |
| ||||||||||||||||||
Class/type ofshares if possible usingthe ISIN CODE | Situation previousto the triggeringtransaction | Resulting situation after the triggering transaction |
| ||||||||||||||||
NumberofShares | NumberofVotingRights | Numberof shares | Number of votingrights | % of voting rights |
| ||||||||||||||
Direct | Indirect | Direct | Indirect | Direct | Indirect | ||||||||||||||
Ordinary Shares
GB0033278473 | - | - | 4,750,000 | 4,750,000 | 3.95% | ||||||||||||||
| |||||||||||||||||||
B: Qualifying Financial Instruments |
| ||||||||||||||||||
Resulting situation after the triggering transaction |
| ||||||||||||||||||
Type of financialinstrument | Expirationdate | Exercise/Conversion Period | Number of votingrights that may beacquired if theinstrument isexercised/ converted. | % of votingrights |
| ||||||||||||||
n/a | n/a | n/a | n/a | n/a |
| ||||||||||||||
| |||||||||||||||||||
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments |
| ||||||||||||||||||
Resulting situation after the triggering transaction |
| ||||||||||||||||||
Type of financialinstrument | Exercise price | Expiration date | Exercise/Conversion period | Number of voting rights instrument refers to
| % of voting rights
|
| |||||||||||||
Nominal | Delta |
| |||||||||||||||||
| |||||||||||||||||||
| |||||||||||||||||||
Total (A+B+C) |
| ||||||||||||||||||
Number of voting rights | Percentage of voting rights |
| |||||||||||||||||
4,750,000 | 3.95% |
| |||||||||||||||||
9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: | |||
Proxy Voting: | |||
10. Name of the proxy holder: | n/a | ||
11. Number of voting rights proxy holder will cease to hold: | n/a | ||
12. Date on which proxy holder will cease to hold voting rights: | n/a | ||
13. Additional information: | |||
14. Contact name: | Derek Martin | ||
15. Contact telephone number: | 01483 685670 | ||
Related Shares:
Futura Medical